108 related articles for article (PubMed ID: 9437737)
1. Comparative study of in vitro and in vivo activities of bombesin pseudopeptide analogs modified on the C-terminal dipeptide fragment.
Azay J; Nagain C; Llinares M; Devin C; Fehrentz JA; Bernad N; Roze C; Martinez J
Peptides; 1998; 19(1):57-63. PubMed ID: 9437737
[TBL] [Abstract][Full Text] [Related]
2. Effect of a new bombesin receptor antagonist, (E)-alkene bombesin isostere, on amylase release from rat pancreatic acini.
Wada M; Doi R; Hosotani R; Higashide S; Ibuka T; Habashita H; Nakai K; Fujii N; Imamura M
Pancreas; 1995 Apr; 10(3):301-5. PubMed ID: 7542772
[TBL] [Abstract][Full Text] [Related]
3. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity.
Coy DH; Taylor JE; Jiang NY; Kim SH; Wang LH; Huang SC; Moreau JP; Gardner JD; Jensen RT
J Biol Chem; 1989 Sep; 264(25):14691-7. PubMed ID: 2475489
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of C-terminal hydroxamide analogues of bombesin.
Devin C; Bernad N; Cristau M; Artis-Noel AM; Heitz A; Fehrentz JA; Martinez J
J Pept Sci; 1999 Apr; 5(4):176-84. PubMed ID: 10323197
[TBL] [Abstract][Full Text] [Related]
5. JMV641: a potent bombesin receptor antagonist that inhibits Swiss 3T3 cell proliferation.
Azay J; Gagne D; Devin C; Llinares M; Fehrentz JA; Martinez J
Regul Pept; 1996 Aug; 65(1):91-7. PubMed ID: 8876041
[TBL] [Abstract][Full Text] [Related]
6. Actions of novel bombesin receptor antagonists on pancreatic secretion in rats.
Jaworek J; Konturek PK; Konturek SJ; Cai RZ; Schally AV
Eur J Pharmacol; 1992 Apr; 214(2-3):239-45. PubMed ID: 1381317
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of bombesin constrained analogues.
Cristau M; Devin C; Oiry C; Chaloin O; Amblard M; Bernad N; Heitz A; Fehrentz JA; Martinez J
J Med Chem; 2000 Jun; 43(12):2356-61. PubMed ID: 10882361
[TBL] [Abstract][Full Text] [Related]
8. A synthetic glycine-extended bombesin analogue interacts with the GRP/bombesin receptor.
Oiry C; Pannequin J; Bernad N; Artis AM; Galleyrand JC; Devin C; Cristau M; Fehrentz JA; Martinez J
Eur J Pharmacol; 2000 Sep; 403(1-2):17-25. PubMed ID: 10969139
[TBL] [Abstract][Full Text] [Related]
9. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV
Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427
[TBL] [Abstract][Full Text] [Related]
10. Covalently cyclized agonist and antagonist analogues of bombesin and related peptides.
Coy DH; Jiang NY; Kim SH; Moreau JP; Lin JT; Frucht H; Qian JM; Wang LW; Jensen RT
J Biol Chem; 1991 Sep; 266(25):16441-7. PubMed ID: 1715866
[TBL] [Abstract][Full Text] [Related]
11. Effects of potent bombesin antagonist on exocrine pancreatic secretion in rats.
Varga G; Reidelberger RD; Liehr RM; Bussjaeger LJ; Coy DH; Solomon TE
Peptides; 1991; 12(3):493-7. PubMed ID: 1717952
[TBL] [Abstract][Full Text] [Related]
12. des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists.
Wang LH; Coy DH; Taylor JE; Jiang NY; Moreau JP; Huang SC; Frucht H; Haffar BM; Jensen RT
J Biol Chem; 1990 Sep; 265(26):15695-703. PubMed ID: 1697594
[TBL] [Abstract][Full Text] [Related]
13. Partial agonist activity of the bombesin-receptor antagonist [Leu14-psi-CH2-NH-Leu13]-bombesin in frog peptic cells.
Dickinson KE; Uemura N; Sekar MC; McDaniel HB; Anderson W; Coy DH; Hirschowitz BI
Biochem Biophys Res Commun; 1988 Dec; 157(3):1154-8. PubMed ID: 2462868
[TBL] [Abstract][Full Text] [Related]
14. Syntheses and biological activities of potent bombesin receptor antagonists.
Llinares M; Devin C; Chaloin O; Azay J; Noel-Artis AM; Bernad N; Fehrentz JA; Martinez J
J Pept Res; 1999 Mar; 53(3):275-83. PubMed ID: 10231715
[TBL] [Abstract][Full Text] [Related]
15. Potent pseudopeptide bombesin-like agonists and antagonists. Correlation of ordered conformation of bombesin analogs to receptor activity.
Edwards JV; McLean LR; Wade AC; Eaton SR; Cashman EA; Hagaman KA; Fanger BO
Int J Pept Protein Res; 1994 Apr; 43(4):374-83. PubMed ID: 8045684
[TBL] [Abstract][Full Text] [Related]
16. Bombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides.
Sekar MC; Uemura N; Coy DH; Hirschowitz BI; Dickinson KE
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):163-9. PubMed ID: 1720612
[TBL] [Abstract][Full Text] [Related]
17. [Ala6]gastrin-releasing peptide-10: an analogue with dissociated biological activities.
Mukai H; Kawai K; Suzuki S; Ohmori H; Yamashita K; Munekata E
Am J Physiol; 1989 Aug; 257(2 Pt 1):E235-40. PubMed ID: 2669516
[TBL] [Abstract][Full Text] [Related]
18. Biological activity and three-dimensional structure of an agonist analog of bombesin.
Condamine E; Chapdeleine G; Demarcy L; Duclos JF; Davoust D; Llinares M; Azay J; Martinez J; Chapelle S
J Pept Res; 1998 Jan; 51(1):55-64. PubMed ID: 9495592
[TBL] [Abstract][Full Text] [Related]
19. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
Cai RZ; Reile H; Armatis P; Schally AV
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12664-8. PubMed ID: 7809097
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
